FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
- Status
- RECRUITING
- Phase
- PHASE2
A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
- Status
- COMPLETED
- Phase
- N/A
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
- Status
- RECRUITING
- Phase
- NA
Pulmonary and Extrapulmonary Impairments in Patients With Lung Cancer Awaiting Surgery
- Status
- COMPLETED
- Phase
- N/A
Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
- Status
- COMPLETED
- Phase
- PHASE1
Detecting Lung Cancer Based on Exhaled Breath
- Status
- COMPLETED
- Phase
- N/A
ESCAP-2020-CPHG: Treatment Strategies Follow-up Implemented During the First Three Years Following Primary Lung Cancer (PLC) Diagnosed in KBP-2020-CPHG Cohort Patients
- Status
- UNKNOWN
- Phase
- N/A
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation
- Status
- UNKNOWN
- Phase
- NA
Manchester Lung Health Study
- Status
- UNKNOWN
- Phase
- N/A
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection
- Status
- COMPLETED
- Phase
- N/A
Study on Skin Toxicities Induced by Cancer Treatments
- Status
- COMPLETED
- Phase
- NA
Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020
- Status
- RECRUITING
- Phase
- N/A